Lotus Pharm vs NeoCore Technology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and NeoCore Technology (4131) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ NeoCore Technology

0%+2591%-43%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYNeoCore TechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$19.9 million+34.9%
Sep 2026NT$2.77 billion+128.0%NT$16.5 million+1.5%
Aug 2026NT$2.11 billion+81.7%NT$16 million+10.7%
Jul 2026NT$2.49 billion+3.9%NT$16.8 million-31.5%
Jun 2026NT$3.4 billion+225.5%NT$34.1 million+96.4%
May 2026NT$2.32 billion+105.8%NT$33.6 million+135.4%
Apr 2026NT$3.09 billion+19.9%NT$28 million+26.9%
Mar 2026NT$4.35 billion+173.6%NT$27.3 million+41.7%
Feb 2026NT$2.24 billion+131.5%NT$16 million-42.9%
Jan 2026NT$2.05 billion-5.5%NT$17.2 million-23.2%
Dec 2025NT$2.44 billion+66.9%NT$24.6 million+2,590.6%
Nov 2025NT$1.06 billion-0.2%NT$26.9 million+396.7%
Oct 2025NT$2.75 billion+46.0%NT$14.8 million+178.7%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16